...
首页> 外文期刊>Toxicological sciences: An official journal of the Society of Toxicology >Is toluene diamine a sensitizer and is there cross-reactivity between toluene diamine and toluene diisocyanate?
【24h】

Is toluene diamine a sensitizer and is there cross-reactivity between toluene diamine and toluene diisocyanate?

机译:甲苯二胺是否是敏化剂?甲苯二胺和甲苯二异氰酸酯之间是否有交叉反应性?

获取原文
获取原文并翻译 | 示例
           

摘要

Toluene diamine (TDA) is formed when toluene diisocyanate (TDI), a potent sensitizer, comes in contact with an aqueous environment. The sensitizing capacity of TDA and the cross-reactivity between TDI and TDA are unknown. TDA (5-25%) and TDI (0.3%), dissolved in acetone/olive oil (AOO) (4:1) were tested in the mouse local lymph node assay (LLNA). To determine the capacity of TDA to elicit an asthmatic response and to determine the cross-reaction with TDI, a locally developed experimental mouse model of chemical-induced asthma was used. On days 1 and 8, BALB/c mice received 20 microl of TDI (0.3%), TDA (20%), or AOO (4:1) on each ear. On day 15, they received an intranasal instillation of TDI (0.1%), TDA (0.5%) or AOO (3:2). The EC(3) of TDA in the LLNA is 19%. In the model of chemical-induced asthma, TDI induced a ventilatory response [increased Penh after challenge; increased airway hyperreactivity (AHR)], inflammatory changes (bronchoalveolar lavage neutrophils), and immunological changes (increased CD19(+) lymphocytes, IL-4 and total serum IgE), whereas TDA did not show any of these responses. Mice sensitized with TDI and challenged with TDA also did not show any airway or inflammatory response, although they had increased levels of total serum IgE. Mice sensitized with TDA and challenged with TDI did not show any response. According to the classification of sensitizers in the LLNA, TDA is a weak dermal sensitizer. In the experimental mouse model of chemical-induced asthma, TDA does not act as a respiratory sensitizer, at the concentration used. No cross-reactivity between TDI and TDA was found.
机译:当强力敏化剂甲苯二异氰酸酯(TDI)与水性环境接触时,会形成甲苯二胺(TDA)。 TDA的敏化能力以及TDI和TDA之间的交叉反应性是未知的。在小鼠局部淋巴结试验(LLNA)中测试了溶解在丙酮/橄榄油(AOO)(4:1)中的TDA(5-25%)和TDI(0.3%)。为了确定TDA引起哮喘反应的能力并确定与TDI的交叉反应,使用了局部开发的化学诱导哮喘实验小鼠模型。在第1天和第8天,BALB / c小鼠的每只耳朵接受20微升TDI(0.3%),TDA(20%)或AOO(4:1)。在第15天,他们接受TDI(0.1%),TDA(0.5%)或AOO(3:2)的鼻内滴注。 LLNA中TDA的EC(3)为19%。在化学性哮喘模型中,TDI引起通气反应[激发后Penh升高;气道高反应性(AHR)增加],炎症变化(支气管肺泡灌洗中性粒细胞)和免疫学变化(CD19(+)淋巴细胞,IL-4和总血清IgE升高),而TDA没有显示任何这些反应。用TDI致敏并用TDA攻击的小鼠也没有表现出任何气道或炎症反应,尽管它们的总血清IgE水平升高。用TDA致敏并用TDI攻击的小鼠未显示任何反应。根据LLNA中敏化剂的分类,TDA是一种较弱的皮肤敏化剂。在化学诱导的哮喘实验小鼠模型中,在使用的浓度下,TDA不能充当呼吸道致敏剂。在TDI和TDA之间未发现交叉反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号